Aristeia Capital’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300,000
Closed -$3.56M 562
2025
Q1
$3.56M Hold
300,000
0.09% 107
2024
Q4
$3.5M Hold
300,000
0.11% 107
2024
Q3
$3.44M Hold
300,000
0.07% 97
2024
Q2
$3.38M Hold
300,000
0.07% 74
2024
Q1
$3.33M Hold
300,000
0.07% 49
2023
Q4
$3.29M Sell
300,000
-510,824
-63% -$5.56M 0.06% 52
2023
Q3
$8.81M Hold
810,824
0.24% 37
2023
Q2
$8.65M Buy
810,824
+101,400
+14% +$1.07M 0.19% 61
2023
Q1
$7.44M Buy
709,424
+538,324
+315% +$5.59M 0.17% 126
2022
Q4
$1.75M Buy
171,100
+35,600
+26% +$361K 0.04% 302
2022
Q3
$1.36M Buy
+135,500
New +$1.36M 0.02% 390

Other funds holding RENE

Aristeia Capital's RENE Position: Q2 2025 in Review

Aristeia Capital sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 300,000 shares — an estimated $3.56M sold.

Aristeia Capital first reported a position in RENE in Q3 2022 and held it in 11 quarters. The position peaked at $8.81M in Q3 2023. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Aristeia Capital reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Aristeia Capital sold 300,000 Cartesian Growth Corp II shares in Q2 2025, an estimated $3.56M.
  • Aristeia Capital first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 11 quarters.
  • Aristeia Capital's Cartesian Growth Corp II position peaked at $8.81M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Aristeia Capital's 13F filing for Q2 2025, filed 14 Aug 2025.